Mitani Sangyo (8285) · RiskMitigated
Legal and Regulatory Risks Across Multiple Fields, Including the Cancellation of Permits and Approvals
First written in FY2021. 1 of 2 entries say "Mitigated", first in FY2026. Latest entry: FY2026.
2entries
6years
0from disclosures
How it moved
Same theme, other companies
Risk of Regulatory Approvals and Legal Amendments Across Multiple Businesses, Including Pharmaceuticals, Food and Alcoholic BeveragesA theme 21 companies write about · 21 as a headwind · 0 as a tailwind
The whole theme swung hardest in 2026: 4 of 7 companies on the "Worse" side.
1 other company's latest entry also says "Mitigated".
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 21 companies compared. The sentences above are computed from all 21.Full recordFilings, disclosures and news, newest first
- FY2026MitigatedAnnual report
「As of the present time, no circumstances have arisen that would result in the revocation of any permits or approvals required for the group to conduct its business activities.」
While continuing to recognize the risks associated with laws, regulations and permits across multiple sectors, the company stated that no circumstances requiring permit revocation had arisen, and described regular checks, responses to legal amendments, training and its whistleblowing system as countermeasures. - FY2021First statedAnnual report
「Because the group handles a wide range of products and services, it is subject to a broad range of applicable laws and regulations, including the Pharmaceuticals and Medical Devices Act, as well as the various laws and regulations of each country in which it operates overseas.」
The company described the risk that the wide range of domestic and overseas laws and regulations, including the Pharmaceuticals and Medical Devices Act, could restrict business activities or result in additional costs.